Sort
15,842 grants matching “pancreatic cancer”
Molecular Imaging in the Treatment of Kaposi's Sarcoma
$191,503Richard F. Ambinder · Johns Hopkins University · P50 · FY2013 · CA
Familial Markers of Risk
$191,484Alison P Klein · Johns Hopkins University · P50 · FY2014 · CA
Novel Small Molecule MDM2 Inhibitors for Pancreatic Cancer Therapy
$191,455Ruiwen Zhang · Texas Tech University Health Scis Center · R01 · FY2017 · CA
Dissecting the roles of stellate cells in pancreas cancer progression
$191,400Paolo Provenzano · Fred Hutchinson Cancer Research Center · R21 · FY2010 · CA
Hedgehog Acyltransferase as a target in cancer
$191,291Marilyn D Resh · Sloan-Kettering Inst Can Research · R21 · FY2015 · CA
Metabolic Syndrome as Pancreatic Cancer Etiology
$191,250Jin-Rong Zhou · Beth Israel Deaconess Medical Center · R21 · FY2008 · CA
CLINICAL TRIALS CORE
$191,247Tomislav Dragovich · University Of Arizona · P01 · FY2010 · CA
The DAXX/ATRX/H3.3 axis in ERV regulation and tumor suppression
$191,193Amanda Rietta Wasylishen · University Of Cincinnati · K22 · FY2023 · CA
The DAXX/ATRX/H3.3 axis in ERV regulation and tumor suppression
$191,193Amanda Rietta Wasylishen · University Of Cincinnati · K22 · FY2022 · CA
Pancreatic Stem Cells and Cancer
$191,183Courtney Wayne Houchen · University Of Oklahoma Hlth Sciences Ctr · R21 · FY2010 · CA
Novel Anti-HER3 Strategy for Pancreatic Cancer
$191,183Tong Zhou · University Of Alabama At Birmingham · R21 · FY2013 · CA
FOXP3-microRNA146-NFkB Axis in Tumor Suppression
$191,183Lizhong Wang · University Of Alabama At Birmingham · R21 · FY2012 · CA
Virotherapy for pancreatic cancer with wildtype and armed Myxoma viruses
$191,183Grant McFadden · University Of Florida · R21 · FY2011 · CA
Evaluation of MSP Antagonists for the Treatment of Pancreatic Cancer
$191,143Joseph W Harding · Washington State University · R21 · FY2014 · CA
Administrative and Biostatistics Core
$191,008Seung K Kim · Stanford University · P01 · FY2021 · CA
Solid-Phase Platform for the Preparation of Dual-receptor Targeted PET Agents
$190,781Dexing Zeng · University Of Pittsburgh At Pittsburgh · R21 · FY2013 · EB
Flavonoids in Pancreatic Carcinogenesis & Angiogenesis/Hines, Oscar
$190,555Oscar Joe Hines · University Of California Los Angeles · P01 · FY2011 · AT
Mass Spec Proteomics
$190,488Edward E Partridge · University Of Alabama At Birmingham · P30 · FY2014 · CA
Familial Markers of Risk
$190,455Alison P Klein · Johns Hopkins University · P50 · FY2013 · CA
Proj. 1: Genetic Pathways Governing Pancreatic Ductal Adenocarcinoma
$190,354Ronald Anthony Depinho · Dana-Farber Cancer Inst · P01 · FY2006 · CA
Prognostic potential of low-level mutations in meylodysplastic syndrome
$190,313G. Mike Makrigiorgos · Dana-Farber Cancer Inst · R21 · FY2014 · CA
High Throughput Digital Droplet ELISA for Ultrasensitive Multiplexed Diagnostics
$190,306David Aaron Issadore · University Of Pennsylvania · R21 · FY2021 · CA
Harnessing Cytomegalovirus (CMV)-specific T-cells for pancreatic cancer immunotherapy
$190,283Tatiana Hurtado De Mendoza · University Of California, San Diego · R21 · FY2025 · CA
Combined Modality Targeted Therapy of Pancreatic Cancer with Death Receptor
$190,180Donald J Buchsbaum · University Of Alabama At Birmingham · P50 · FY2012 · CA
Identifying chromatin factors essential for DNA repair using a novel high-throughput screening methodology
$190,115Thomas L Clarke · Boston University Medical Campus · R00 · FY2024 · ES